Crisis de opioides, salud pública y compliance

Abstract

Opioids as substances that mitigate the effects of chronic and terminal illnesses have been the subject of discussion in the international arena, not only for their medical use but for the recreational purpose that generates addiction in consumers. This work begins with an analysis of strictly medicinal use since the State restricts its therapeutic use in favor of patients. The objective of the degree work is to analyze the joint responsibility between the State and private companies, against the addiction caused by medications that have this substance as an active ingredient. In this order, the document develops, in the first place, public health as a scenario of State protection; secondly, compliance as a regulatory system of criminal and administrative liability inherent to legal persons. The foregoing, considering that companies specialize in creating, manufacturing, and distributing medicines, must set pharmaceutical compliance that demonstrates the external dangers of the company, as well as the type of production, manufacturing, and marketing.